Fungal skin infections are one of the most common dermatological problems, impacting patients' quality of life. This study examined the efficacy of modern antifungal medications in 30 patients treated at the Namangan branch of the Republican Center for Dermatovenereology and Cosmetology. Microscopy, culture diagnostics, and clinical assessment of symptoms were used. The results demonstrate the high efficacy of combination therapy and the need for an individualized approach to drug selection depending on the pathogen.

fungal skin infections, dermatology, antifungal drugs, therapy efficacy, clinical trial

Murray, C. et al. Fungal skin infections: clinical overview. BMC Dermatology. 2021; 21:112-120.

World Health Organization. Fungal infections report. Geneva: WHO; 2022. p. 34-40.

Rahmanov, A. Antifungal resistance in Uzbekistan. Tashkent: Medical Press; 2021. p. 45-63.

Smith, J., Lee, K., Thompson, R. Novel antifungal therapies. J Clin Microbiol. 2022; 60(4):101-115.

ECDC. Antifungal resistance surveillance 2022. Stockholm; 2022. p. 15-28.

Джураева, Н. А., Каримов, М. Х. Современные подходы к терапии грибковых инфекций. 6. Вестник дерматовенерологии Узбекистана. 2021; 3(1):25-34.

Олийхонов, А. Т. Диагностика и лечение грибковых заболеваний кожи. Ташкент; 2020. p. 78-90.

Абдурахманова, Л. М. Грибковые инфекции кожи: современная диагностика и терапия. Самарканд; 2022. p. 102-118.

Centers for Disease Control and Prevention (CDC). Treatment guidelines for fungal infections. Atlanta; 2023. p. 50-65.

Lee, H., Park, J., Kim, S. Individualized therapy for cutaneous fungal infections. Int J Dermatol. 2020; 59(8):950-962.